ContextVision AB presents upgraded software at key US radiology conference

Stockholm, 30 November, 2015

ContextVision AB (OSE: COV), the medical imaging software company, today announced that the Company this week is presenting upgraded versions of all its image enhancement and analysis software for ultrasound at the industry's most important gathering, the annual meeting of the Radiological Society of North America (RSNA).

ContextVision is the global market leader in its specialized software niche, and the software solutions for 2D/3D/4D ultrasound now presented are significantly upgraded from the previous versions.

2D ultrasound remains the largest part of the ultrasound market, and ContextVision is now introducing the fifth generation of software for this application.

The Company is the definitive technology leader in the more sophisticated 3D ultrasound segment, where a significant larger amount of data needs to be processed in real time. ContextVision's software is the only one able to offer its level of real time resolution in 3D ultrasound.

About ContextVision
ContextVision's cutting edge technology helps doctors interpret medical images, a crucial basis for accurate diagnosis and treatment. ContextVision provides state-of-the-art medical image analysis and enhancement software to equipment manufacturers worldwide. The company started out as an industry pioneer more than 30 years ago, and is today the global leader within specialized software for 2D/3D/4D Ultrasound, MRI, X-Ray, Mammography and CT.  The company is investing heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.

For further information, please contact ContextVision's CEO, Anita Tollstadius, telephone +46 70 337 30 26.